My Voice: Laryngectomy and Head and Neck Cancer Information

Created by Itzhak Brook MD a physician and a laryngectomee. It contains information about head and neck cancer, life after laryngectomy, and manuscripts and videos about Dr. Brook's personal experiences as a patient with throat cancer. It has information about side effects of radiation and chemotherapy; methods of speaking; airway, mucus, stoma, voice prosthesis; eating and swallowing; medical, dental and psychological issues; respiration; anesthesia; travelling; and COVID-19.

About Itzhak Brook MD

Dr. Itzhak Brook: Dr. Itzhak Brook is a physician who specializes in pediatrics and infectious diseases. He is a Professor of Pediatrics at Georgetown University Washington D.C. and his areas of expertise are anaerobic and head and neck infections including sinusitis. He has done extensive research on respiratory tract infections and infections following exposure to ionizing radiation. Dr. Brook served in the US Navy for 27 years. He is the author of 9 medical textbooks, 3 autobiographical books, 155 medical book chapters and many scientific publications. He is an editor of four and associate editor of four medical journals. He is a board member of the Head and Neck Cancer Alliance. Dr. Brook is the recipient of the 2012 J. Conley Medical Ethics Lectureship Award by the American Academy of Otolaryngology-Head and Neck Surgery. Dr. Brook was diagnosed with throat cancer in 2006.

View my complete profile

My Voice: Laryngectomy and Head and Neck Cancer Information

Pages

Head and Neck Squamous Cell Carcinona ( HNSCC) is more common and advanced in those living with Human Immunodeficiency Virus (HIV)

Use of nonsteroidal anti-inflammatory drugs improved patient survival for PIK3CA-altered head and neck cancer (HNC).

Head and Neck Cancer: Through the Eyes of a Patient

"The Laryngectomee Guide” is available in 28 languages

Positive initial margins is associated with poorer disease free survival (DFS) among patients with primary laryngeal squamous cell carcinoma who undergo total laryngectomy.

Immunotherapy in head and neck squamous cell carcinoma

Association of neurocognitive deficits with radiotherapy or chemoradiotherapy for patients with head and neck cancer